How to Get Losartan in New Hampshire

What Losartan Treats and Why Providers Prescribe It

Losartan is an angiotensin II receptor blocker (ARB) that lowers blood pressure by preventing angiotensin II from binding to AT1 receptors in vascular smooth muscle. The FDA approved losartan (brand name Cozaar) in 1995 for hypertension, making it the first ARB to reach the U.S. Market 1. Providers in New Hampshire prescribe it for three primary indications.

Hypertension

The 2017 ACC/AHA hypertension guideline lists ARBs, including losartan, as a first-line option for adults with stage 1 or stage 2 hypertension 2. A typical starting dose is 50 mg once daily, with a maximum of 100 mg daily. Losartan produces mean systolic blood pressure reductions of 5.5 to 10.5 mmHg at standard doses 1.

Diabetic Nephropathy

The RENAAL trial (N=1,513) demonstrated that losartan 50 to 100 mg daily reduced the risk of doubling of serum creatinine by 25% and end-stage renal disease by 28% in patients with type 2 diabetes and nephropathy, compared with placebo 3. The ADA Standards of Care recommend an ARB or ACE inhibitor for patients with diabetes and albuminuria 4.

Stroke Risk Reduction

The LIFE trial (N=9,193) compared losartan-based therapy with atenolol-based therapy in patients with hypertension and left ventricular hypertrophy. Losartan reduced the composite of cardiovascular death, stroke, and myocardial infarction by 13% (p=0.021), with a 25% relative risk reduction in fatal and nonfatal stroke 5.

Prescribing Rules in New Hampshire

New Hampshire residents can obtain a losartan prescription from several types of licensed clinicians. State law and board regulations determine who can prescribe and under what supervision model.

Physicians and DOs

Any MD or DO with a valid New Hampshire medical license and active DEA registration (though losartan is not a controlled substance, many prescribing systems require one) can prescribe losartan without restrictions. Board-certified internists, family medicine physicians, cardiologists, nephrologists, and endocrinologists are the most common prescribers.

Nurse Practitioners

New Hampshire grants full practice authority to advanced practice registered nurses (APRNs), including nurse practitioners, under RSA 326-B. NPs in New Hampshire can prescribe, diagnose, and manage losartan therapy independently without a collaborative physician agreement 6. This policy aligns with the National Academy of Medicine recommendation to allow NPs to practice to the full extent of their education and training.

Physician Assistants

Physician assistants in New Hampshire prescribe under a collaborative agreement with a supervising physician. PAs can initiate losartan, adjust doses, and order the required monitoring labs within the scope of their agreement. The NH Board of Medicine oversees PA practice standards.

Telehealth Access in New Hampshire

Telehealth is fully authorized for prescribing losartan in New Hampshire. The state adopted permanent telehealth parity legislation (SB 150, effective January 2022), which requires commercial insurers to cover telehealth services at the same rate as in-person visits. This makes remote consultations a practical path for patients in rural Grafton, Coos, or Carroll counties where in-person cardiology or nephrology offices may be sparse.

How a Telehealth Visit Works

A telehealth provider reviews your medical history, blood pressure readings (home monitoring or recent clinic reading), and baseline labs. If losartan is appropriate, the clinician sends an electronic prescription directly to a New Hampshire pharmacy. The AHA endorses home blood pressure monitoring with validated oscillometric devices as a reliable tool for telehealth-based hypertension management 7.

Interstate Prescribing

Clinicians prescribing via telehealth must hold a New Hampshire medical license or participate in a recognized interstate compact (such as the Interstate Medical Licensure Compact, of which New Hampshire is a member). Out-of-state NPs may use the APRN Compact if New Hampshire has enacted it.

Required Labs Before Starting Losartan

Clinicians should obtain baseline labs before initiating losartan therapy. The FDA label and ACC/AHA guidelines specify the following panels 1 2.

Baseline Panel

• Serum creatinine and eGFR: to assess kidney function and detect renal artery stenosis risk
• Serum potassium: losartan can raise potassium levels; baseline K+ above 5.0 mEq/L warrants caution
• Comprehensive metabolic panel (CMP): captures liver enzymes (rare hepatotoxicity reported), glucose, and electrolytes in a single draw

Follow-Up Monitoring

Repeat serum creatinine and potassium within 2 to 4 weeks after initiation or dose increase. A creatinine rise of more than 30% from baseline should prompt reevaluation. The KDIGO 2021 clinical practice guideline recommends continuing an ARB if eGFR decline is <30% from baseline within 4 weeks, as initial dips often stabilize and long-term renal outcomes improve 8.

Where to Get Labs in New Hampshire

Quest Diagnostics and Labcorp have patient service centers in Manchester, Nashua, Concord, and Portsmouth. Some telehealth platforms partner directly with lab networks, letting patients complete blood work at a nearby draw site with results sent to the prescribing clinician. Hospital-affiliated labs at Dartmouth-Hitchcock (Lebanon), Elliot Health System (Manchester), and Catholic Medical Center (Manchester) also process routine panels.

Pharmacy Options in New Hampshire

Once you have a prescription, several pharmacy types can fill it.

Retail Chains

CVS, Walgreens, Rite Aid, and Walmart pharmacies stock generic losartan statewide. Cash prices for a 30-day supply of losartan 50 mg range from $4 at Walmart and Costco to approximately $12 to $15 at chain pharmacies without a discount card. Generic losartan has been available since Teva Pharmaceuticals launched the first generic version after patent expiry in 2010 9.

Independent and 503A Compounding Pharmacies

New Hampshire licenses 503A compounding pharmacies that can prepare custom losartan formulations (such as oral suspensions for patients who cannot swallow tablets) based on a patient-specific prescription. The FDA distinguishes 503A pharmacies (patient-specific, under a prescription) from 503B outsourcing facilities (which can prepare without patient-specific prescriptions) 10.

Mail-Order Pharmacies

Mail-order services such as Express Scripts, OptumRx, and Mark Cuban Cost Plus Drugs ship to New Hampshire addresses. Mail-order is often cheaper for 90-day supplies. Cost Plus Drugs lists generic losartan 50 mg at $3.90 for 30 tablets.

Insurance Coverage and Cost

Losartan is one of the most affordable generic antihypertensives. Its cost picture varies by coverage type.

Commercial Insurance

Most commercial plans in New Hampshire place generic losartan on Tier 1 (preferred generic) with copays of $0 to $10 per month. The Affordable Care Act mandates coverage of preventive services, and multiple commercial insurers classify antihypertensive medications as preventive for patients with diagnosed hypertension 11.

Medicare Part D

Generic losartan is covered under nearly all Medicare Part D formularies at Tier 1 or Tier 2. Beneficiaries in the coverage gap (donut hole) pay 25% of the negotiated price, which for losartan typically amounts to $1 to $3 per month. The Medicare Plan Finder (medicare.gov) allows comparison of specific plan copays by ZIP code.

New Hampshire Medicaid

New Hampshire Medicaid (NH Medicaid Care Management) does not currently list losartan on its preferred drug list for hypertension, heart failure, or diabetic nephropathy. Medicaid enrollees may need prior authorization or may be steered toward preferred ARBs or ACE inhibitors (such as lisinopril) on the state formulary. Providers can submit a prior authorization request through the state's pharmacy benefit manager if losartan is clinically necessary (for example, in patients with ACE inhibitor cough).

Uninsured Patients

Patients without insurance can use GoodRx, RxSaver, or manufacturer discount programs to reduce costs. Generic losartan at $4 to $15 monthly is already one of the lowest-cost antihypertensives available, comparable in price to lisinopril and amlodipine 12.

Prior Authorization in New Hampshire

Prior authorization for losartan is uncommon on commercial plans because it is a generic Tier 1 drug. When required (primarily under Medicaid or certain Medicare Advantage plans), the process follows a standard pathway.

Documentation Needed

• Diagnosis code (ICD-10): I10 for essential hypertension, E11.22 for type 2 diabetes with diabetic nephropathy, I50.9 for heart failure
• Clinical rationale if an ACE inhibitor was tried first and why the switch is necessary (ACE inhibitor cough occurs in 5 to 35% of patients, more commonly in women and patients of East Asian descent) 13
• Baseline labs (creatinine, potassium, eGFR)
• Blood pressure log showing inadequate control on current therapy, if switching from another agent

Timeline

Most pharmacy benefit managers in New Hampshire process urgent prior authorization requests within 24 hours and standard requests within 72 hours. If denied, patients and providers can appeal through the insurer's internal review process or file a complaint with the NH Insurance Department.

Transferring a Losartan Prescription to New Hampshire

Patients relocating to New Hampshire can transfer an active losartan prescription from any U.S. State. The process is straightforward.

Pharmacy-to-Pharmacy Transfer

Call or visit a New Hampshire pharmacy and provide the name and phone number of your current out-of-state pharmacy. The receiving pharmacist contacts the transferring pharmacy directly. Generic losartan transfers are processed same-day in most cases. Controlled substance transfer rules do not apply here because losartan is not a scheduled drug.

New Prescription from a NH Provider

If your out-of-state prescription has no remaining refills, or your previous provider cannot transfer, a New Hampshire clinician (in-person or telehealth) can write a new prescription after reviewing your records. Bring or have your previous provider fax your medication list, recent labs, and blood pressure history.

Special Populations and Safety Considerations

Losartan carries a boxed warning for fetal toxicity. It is contraindicated in pregnancy (Category D) and should be discontinued as soon as pregnancy is detected 1. Women of reproductive age starting losartan in New Hampshire should receive counseling about contraception.

Older Adults

The 2023 AHA/ACC guidelines do not mandate dose reduction in older adults, but starting at 25 mg daily is reasonable for patients over 75 or those with volume depletion 14. Monitor orthostatic blood pressure at follow-up visits.

Patients with Hepatic Impairment

Losartan undergoes hepatic metabolism via CYP2C9 and CYP3A4 to form its active metabolite, E-3174 (EXP3174), which is 10 to 40 times more potent at the AT1 receptor than the parent compound. The FDA label recommends a starting dose of 25 mg in patients with hepatic impairment 1.

Drug Interactions

Avoid combining losartan with aliskiren in patients with diabetes or eGFR <60 mL/min/1.73 m². NSAIDs (ibuprofen, naproxen) can blunt losartan's antihypertensive effect and increase the risk of acute kidney injury, particularly in older adults or those with pre-existing CKD 15. Potassium-sparing diuretics and potassium supplements increase hyperkalemia risk.

What to Expect After Starting Losartan

Blood pressure typically begins to decrease within 1 to 2 weeks, with maximal effect at 3 to 6 weeks after initiation or dose adjustment. The LIFE trial measured its primary endpoint outcomes at a mean follow-up of 4.8 years, reinforcing that long-term adherence yields the greatest benefit 5. Common side effects include dizziness (2.4%), upper respiratory infection (7.9%), and nasal congestion (1.3%), based on rates reported in the FDA prescribing information 1. Angioedema, the primary safety concern with ACE inhibitors, occurs rarely with ARBs. A meta-analysis of 19 studies (N=138,851) found an ARB-associated angioedema incidence of 0.11% 16.

Patients in New Hampshire should schedule a follow-up lab draw (creatinine and potassium) 2 to 4 weeks after starting therapy. Home blood pressure monitoring with a validated cuff (upper arm, oscillometric) provides reliable data between visits. The target for most adults is <130/80 mmHg per current ACC/AHA guidance 2.